| [1] |
YU Jiajie, ZHANG Zhizhi, LUO Qingqiong, KE Xing.
Predicting early colorectal tumor risk using a deep learning model based on multiple serum tumor markers
[J]. Laboratory Medicine, 2025, 40(3): 253-258.
|
| [2] |
YU Xue, QI Aihong, LI Jinhui, QUAN Zhihui, LI Kui, QIU Yurong.
Application role of an AI-patient based real time quality control intelligent monitoring platform for risk quality management of serum tumor markers
[J]. Laboratory Medicine, 2025, 40(3): 264-270.
|
| [3] |
CHEN Zhijin, WANG Yuting, ZHENG Haiyin, LIU Qingzhong.
Preliminary establishment of the reference range for cytokeratin 19 fragment and analysis of related factors
[J]. Laboratory Medicine, 2025, 40(11): 1070-1074.
|
| [4] |
QI Xinglun, YAO Yifan, SHEN Shushi, YANG Zheng, ZHU Junjie, FAN Lina, YANG Dagan.
Performance evaluation of different large language models in interpreting tumor marker determination reports
[J]. Laboratory Medicine, 2025, 40(11): 1075-1081.
|
| [5] |
LEI Ming, ZHAI Li, WEI Ying, LIN Yichen, GUO Mengyue.
Application of nomogram model based on clinical characteristics and serum tumor markers in differential diagnosis of benign and malignant lung lesions
[J]. Laboratory Medicine, 2024, 39(10): 956-962.
|
| [6] |
GAO Feng.
Research progress of new tumor molecular markers in the age of precision medicine：from accurate diagnosis to precision chemotherapy
[J]. Laboratory Medicine, 2022, 37(4): 309-312.
|
| [7] |
XU Runhao, ZOU Chen, CAO Yun, CHEN Feng, LIU Yijing, ZHANG Shulin, ZHANG Jie.
Roles of serum amino acid determinations in the diagnosis of early non-small-cell lung cancer
[J]. Laboratory Medicine, 2022, 37(12): 1157-1163.
|
| [8] |
XIONG Zhongbo, WANG Lei, YIN Beiqi, DAI Yue, WEI Xiaoqing, LU Pei.
Clinical roles of SAA and CRP in pathological staging and metastasis of gastrointestinal cancer
[J]. Laboratory Medicine, 2022, 37(1): 51-55.
|
| [9] |
MAN Xianfeng, HE Xiaoting, ZHANG Ying, YU Weiwei, WANG Qi, YIN Hanwei, WANG Runjie.
Application of thioredoxin reductase in monitoring the curative effect of lung cancer
[J]. Laboratory Medicine, 2022, 37(1): 56-59.
|
| [10] |
XU Runhao, ZOU Chen, ZHANG Jie, LI Min, ZHANG Shulin.
Application of serum bile acid spectrum in the differential diagnosis of pneumonia and lung cancer
[J]. Laboratory Medicine, 2021, 36(1): 1-7.
|
| [11] |
GAO Feng.
Research improvement of the basis and transformation of tumor markers in clinical laboratories
[J]. Laboratory Medicine, 2019, 34(2): 95-97.
|
| [12] |
ZHANG Li, HE Yao.
Comparative study on reference change values and reference change factors of tumor markers
[J]. Laboratory Medicine, 2019, 34(11): 991-993.
|
| [13] |
LIU Xia, WU Yanyan, WANG Jinling, LAN He, LIU Li, WANG Peichang.
Tumor diagnostic rate and tumor marker determination for 84 patients with typical paraneoplastic antibody positive
[J]. Laboratory Medicine, 2018, 33(8): 702-706.
|
| [14] |
ZHANG Haichen, WANG Hao, SONG Yunxiao, MA Jin.
Combined determination of multiple tumor markers for the diagnosis of primary lung cancer
[J]. Laboratory Medicine, 2018, 33(7): 590-596.
|
| [15] |
WU Yongchun.
Tumor markers for the combined screening of female genital tract cancer and breast cancer
[J]. Laboratory Medicine, 2018, 33(6): 512-515.
|
